Showing 696 results
-
Media Release /- RECORD-1 trial shows RAD001 reduces risk of disease progression by 70%- RAD001 is first and only drug to show significant benefit after failure of approved therapies Sutent(R) or Nexavar(R),** with…
-
Media Release /
-
Media Release /- Unprecedented amount of research reflects depth and breadth of collaboration with investigators worldwide to develop new treatments for diverse forms of cancer- Plenary session to highlight impact…
-
Media Release /
-
Media Release /- Post-unblinding analysis of MA-17 trial data provides evidence for potential benefit of starting Femara up to seven years after finishing tamoxifen- Femara only member of aromatase inhibitor class…
-
Media Release /
-
Media Release /- Outstanding interim results cause independent data monitoring committee to immediately share findings; patients on placebo to be offered everolimus- Everolimus (RAD001) tablet, taken once daily,…
-
Media Release /
-
Media Release /- Tekturna HCT combines first approved direct renin inhibitor with the diuretic hydrochlorothiazide (HCTZ) in a single tablet- Data show combination of Tekturna and HCTZ resulted in significant…
-
Media Release /
